1.
Risk of COVID-19 for patients with cancer
by Wang, Hanping
The lancet oncology, 2020-04, Vol.21 (4), p.e181-e181
2.
Cross-Modality Sharpening of Visual Cortical Processing through Layer-1-Mediated Inhibition and Disinhibition
by Ibrahim, Leena A
Neuron (Cambridge, Mass.), 2016-03-02, Vol.89 (5), p.1031-1045
3.
De novo assembly of soybean wild relatives for pan-genome analysis of diversity and agronomic traits
by Li, Ying-hui
Nature biotechnology, 2014-10, Vol.32 (10), p.1045-1052
4.
Characterization of microRNAs in serum： a novel class of biomarkers for diagnosis of cancer and other diseases
by Chen, Xi
Cell research, 2008, Vol.18 (10), p.997-1006
5.
Transforming Sensory Cues into Aversive Emotion via Septal-Habenular Pathway
by Zhang, Guang-Wei
Neuron (Cambridge, Mass.), 2018-09-05, Vol.99 (5), p.1016-1028.e5
6.
Broad Inhibition Sharpens Orientation Selectivity by Expanding Input Dynamic Range in Mouse Simple Cells
by Liu, Bao-hua
Neuron (Cambridge, Mass.), 2011, Vol.71 (3), p.542-554
7.
Interaural Level Difference-Dependent Gain Control and Synaptic Scaling Underlying Binaural Computation
by Xiong, Xiaorui R
Neuron (Cambridge, Mass.), 2013-08-21, Vol.79 (4), p.738-753
8.
Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine
by Jin, Peng
Nature biotechnology, 2011-01, Vol.29 (1), p.68-72
9.
Sensory Cortical Control of a Visually Induced Arrest Behavior via Corticotectal Projections
by Liang, Feixue
Neuron (Cambridge, Mass.), 2015-05-06, Vol.86 (3), p.755-767
10.
Bentuhua: Culturing Psychotherapy in Postsocialist China
by Zhang, Li
Culture, medicine and psychiatry, 2014-03-25, Vol.38 (2), p.283-305
11.
AAV-Mediated Anterograde Transsynaptic Tagging: Mapping Corticocollicular Input-Defined Neural Pathways for Defense Behaviors
by Zingg, Brian
Neuron (Cambridge, Mass.), 2017-01-04, Vol.93 (1), p.33-47
12.
IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice
by Li, Dong, PhD
Journal of allergy and clinical immunology, 2014, Vol.134 (6), p.1422-1432.e11
13.
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label,...
by Zhou, Caicun, Prof
The lancet oncology, 2011, Vol.12 (8), p.735-742
14.
A Non-canonical Reticular-Limbic Central Auditory Pathway via Medial Septum Contributes to Fear Conditioning
by Zhang, Guang-Wei
Neuron (Cambridge, Mass.), 2018-01-17, Vol.97 (2), p.406-417.e4
15.
Gemcitabine plus cisplatin versus fluorouracil plus cisplatin in recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 trial
by Zhang, Li, Prof
The Lancet (British edition), 2016, Vol.388 (10054), p.1883-1892
16.
Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer
by Yang, Xiao-yan
Cancer letters, 2012, Vol.334 (2), p.338-345
17.
Icotinib versus gefitinib in previously treated advanced non-small-cell lung cancer (ICOGEN): a randomised, double-blind phase 3 non-inferiority trial
by Shi, Yuankai, MD
The lancet oncology, 2013, Vol.14 (10), p.953-961
18.
A genetically encoded fluorescent acetylcholine indicator for in vitro and in vivo studies
by Jing, Miao
Nature biotechnology, 2018-09, Vol.36 (8), p.726-737
19.
Camrelizumab versus investigator's choice of chemotherapy as second-line therapy for advanced or metastatic oesophageal squamous cell carcinoma (ESCORT): a multicentre, randomised,...
by Huang, Jing
The lancet oncology, 2020-06, Vol.21 (6), p.832-842
20.
The Effect of Ex Ante Management Forecast Accuracy on the Post-Earnings-Announcement Drift
by Zhang, Li
The Accounting review, 2012-09-01, Vol.87 (5), p.1791-1818
